{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:05:14Z","timestamp":1767773114862},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,13]]},"DOI":"10.7759\/cureus.31454","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T22:18:25Z","timestamp":1668377905000},"source":"Crossref","is-referenced-by-count":2,"title":["Pembrolizumab-Induced Lichen Planus in a Patient With Non-Small-Cell Lung Carcinoma (NSCLC) That Correlates to Therapeutic Response"],"prefix":"10.7759","author":[{"given":"Aasim","family":"Sehbai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Pembrolizumab Information. (2022). https.\/\/www.cancerresearchuk.org\/about-cancer\/cancer-in-general\/treatment\/cancer-drugs\/drugs\/pembrolizumab."},{"key":"ref2","unstructured":"Lichen Planus. (2022). https.\/\/dermnetnz.org\/topics\/lichen-planus."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1103641","article-title":"Clinical practice. Lichen planus","volume":"366","author":"Le Cleach L","year":"2012","unstructured":"Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012, 366:723-32. 10.1056\/NEJMcp1103641","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1916","article-title":"Pembrolizumab cutaneous adverse events and their association with disease progression","volume":"151","author":"Sanlorenzo M","year":"2015","unstructured":"Sanlorenzo M, Vujic I, Daud A, et al.. Pembrolizumab cutaneous adverse events and their association with disease progression. JAMA Dermatol. 2015, 151:1206-12. 10.1001\/jamadermatol.2015.1916","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2010.00946.x","article-title":"Pathogenesis of oral lichen planus--a review","volume":"39","author":"Roopashree MR","year":"2010","unstructured":"Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus--a review. J Oral Pathol Med. 2010, 39:729-34. 10.1111\/j.1600-0714.2010.00946.x","journal-title":"J Oral Pathol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.03.007","article-title":"Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma","volume":"6","author":"Kwon CW","year":"2020","unstructured":"Kwon CW, Murthy RK, Kudchadkar R, Stoff BK. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma. JAAD Case Rep. 2020, 6:1045-7. 10.1016\/j.jdcr.2020.03.007","journal-title":"JAAD Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.2226","article-title":"Clinical and histologic features of lichenoid mucocutaneous eruptions due to anti-programmed cell death 1 and anti-programmed cell death ligand 1 immunotherapy","volume":"152","author":"Shi VJ","year":"2016","unstructured":"Shi VJ, Rodic N, Gettinger S, et al.. Clinical and histologic features of lichenoid mucocutaneous eruptions due to anti-programmed cell death 1 and anti-programmed cell death ligand 1 immunotherapy. JAMA Dermatol. 2016, 152:1128-36. 10.1001\/jamadermatol.2016.2226","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123368-pembrolizumab-induced-lichen-planus-in-a-patient-with-non-small-cell-lung-carcinoma-nsclc-that-correlates-to-therapeutic-response","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:13Z","timestamp":1707507673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123368-pembrolizumab-induced-lichen-planus-in-a-patient-with-non-small-cell-lung-carcinoma-nsclc-that-correlates-to-therapeutic-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,13]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.31454","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,13]]}}}